Natural Killer Cell Activity and Response to Neoadjuvant Treatment in Breast Cancer Patients
Sofie Høier Gamborg-Kvist, Else Maae, Signe Timm, Ina Mathilde Kjær, Troels Bechmann, Torben Frøstrup Hansen, Line Nederby

TL;DR
This study explores how natural killer cell activity could predict treatment response in breast cancer patients and finds that prednisolone affects these measurements.
Contribution
The study is the first to show that prednisolone impairs natural killer cell activity measurements in breast cancer patients.
Findings
Patients with normal natural killer cell activity had better invasive disease-free survival than those with low activity.
Prednisolone significantly reduced plasma IFNγ levels, indicating impaired natural killer cell activity measurement.
Abstract
No validated biomarkers are available to monitor neoadjuvant treatment effects for breast cancer. Natural killer cell activity (NKA) has shown prognostic potential in other cancers. This study examined the association between NKA and treatment response. Patients had blood samples collected at baseline, before each treatment, and pre- and postoperatively. Plasma IFNγ levels were measured by ELISA as a surrogate marker of NKA, with 250 pg/mL as the cutoff for normal versus low NKA. Study endpoints were residual cancer burden (RCB) class, overall survival (OS), and invasive disease-free survival (IDFS). Seventy-eight patients were included. The five-year IDFS was 88.1% (95% confidence interval (CI) 73.7–94.9%) for patients with normal NKA versus 71.5% (95% CI 40.6–88.2%) for patients with low NKA (p = 0.049) preoperatively. At the fifth treatment cycle, the median IFNγ was 11 pg/mL…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsImmune Cell Function and Interaction · Lymphoma Diagnosis and Treatment · Inflammatory Biomarkers in Disease Prognosis
